| Score 0 | Score 1 | Score ≥2 | p value |
---|---|---|---|---|
Female, N (%) | 11 (38%) | 12 (39%) | 15 (29%) | 0.47 |
Male, N (%) | 18 (62%) | 19 (61%) | 36 (71%) | Â |
Median age, (IQR) yrs | 34.7 (28.7-45) | 43.4 (34.8-51) | 53.9 (34.7-62) | 0.01 |
Median CD duration before surgery (IQR) months | 48 (7-63) | 22 (1-68) | 12 (3-120) | 0.45 |
Median interval from surgery and evaluation (IQR) months | 33.3 (11-59) | 36 (20-66) | 59.6 (25-114) | 0.05 |
Median CDAI (IQR) | 66 (29-93) | 39 (17-94) | 44 (23-144) | 0.19 |
CDAI ≥ 150, N (%) | 2 (7%) | 2 (6%) | 11 (22%) | 0.04 |
CDAI < 150 N (%) | 27 (93%) | 29 (94%) | 40 (78%) | Â |
Presence of symptoms N (%) | 9 (31%) | 12 (39%) | 29 (57%) | 0.11 |
Median ICA wall thickness (IQR) mm | 3 (2.5-3.8) | 7 (6-9) | 10 (9-12) | < 0.001 |
Median neo-terminal ileal extension of increased wall thickness, (IQR) cm | 0 | 1 (1-6.5) | 13 (7-20) | < 0.001 |